Pulmonary thrombosis in 2019-nCoV pneumonia?
作者信息
Marongiu Francesco, Grandone Elvira, Barcellona Doris
机构信息
Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
Atherosclerosis and Thrombosis Unit, IRCCS Ospedale Casa Sollievo della Sofferenza, Foggia, Italy.
出版信息
J Thromb Haemost. 2020 Jun;18(6):1511-1513. doi: 10.1111/jth.14818. Epub 2020 Apr 15.
Abstract
摘要
相似文献
1
Pulmonary thrombosis in 2019-nCoV pneumonia?
J Thromb Haemost. 2020 Jun;18(6):1511-1513. doi: 10.1111/jth.14818. Epub 2020 Apr 15.
2
Response to 'Pulmonary thrombosis in 2019-nCoV pneumonia?'.
J Thromb Haemost. 2020 Jun;18(6):1513-1514. doi: 10.1111/jth.14843. Epub 2020 May 12.
3
Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia.
J Thromb Haemost. 2020 Apr;18(4):786-787. doi: 10.1111/jth.14781. Epub 2020 Mar 24.
4
Covid-19, Angiogenesis, and ARDS Endotypes.
N Engl J Med. 2020 Jul 9;383(2):182-183. doi: 10.1056/NEJMe2018629. Epub 2020 May 21.
5
Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?
Thromb Haemost. 2020 Aug;120(8):1230-1232. doi: 10.1055/s-0040-1712097. Epub 2020 Apr 29.
6
DIC in COVID-19: Implications for prognosis and treatment?
J Thromb Haemost. 2020 Jul;18(7):1798-1799. doi: 10.1111/jth.14878. Epub 2020 Jun 14.
7
Pulmonary Vascular Pathology in Covid-19.
N Engl J Med. 2020 Aug 27;383(9):886-887. doi: 10.1056/NEJMc2022068. Epub 2020 Jul 17.
8
What to do next to control the 2019-nCoV epidemic?
Lancet. 2020 Feb 8;395(10222):391-393. doi: 10.1016/S0140-6736(20)30300-7.
9
Pulmonary Vascular Pathology in Covid-19.
N Engl J Med. 2020 Aug 27;383(9):887. doi: 10.1056/NEJMc2022068. Epub 2020 Jul 17.
10
Pulmonary Vascular Pathology in Covid-19.
N Engl J Med. 2020 Aug 27;383(9):887-888. doi: 10.1056/NEJMc2022068. Epub 2020 Jul 17.
引用本文的文献
1
Is anticoagulative therapy in systemic sclerosis to be reconsidered?
J Scleroderma Relat Disord. 2024 Jun;9(2):81-85. doi: 10.1177/23971983241256250. Epub 2024 Jun 19.
2
Emerging patterns of hypercoagulability associated with critical COVID-19: A review.
Trends Anaesth Crit Care. 2020 Oct;34:4-13. doi: 10.1016/j.tacc.2020.07.004. Epub 2020 Jul 9.
3
A journey to vasculopathy in systemic sclerosis: focus on haemostasis and thrombosis.
Clin Exp Med. 2023 Dec;23(8):4057-4064. doi: 10.1007/s10238-023-01222-x. Epub 2023 Nov 1.
4
Investigation of Pulmonary Artery and Ascending Aorta Morphology in the Coronavirus Disease 2019: A Radioanatomical Study.
Thorac Res Pract. 2023 Jan;24(1):40-44. doi: 10.5152/ThoracResPract.2023.22107.
5
COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: A novel treatment strategy.
Front Med (Lausanne). 2022 Aug 30;9:961027. doi: 10.3389/fmed.2022.961027. eCollection 2022.
6
The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact.
Diabetes Ther. 2022 Oct;13(10):1723-1736. doi: 10.1007/s13300-022-01311-2. Epub 2022 Aug 27.
7
Pharmacotherapy consideration of thrombolytic medications in COVID-19-associated ARDS.
J Intensive Care. 2022 Jul 30;10(1):38. doi: 10.1186/s40560-022-00625-4.
8
The impact of daily troponin I and D-dimer serum levels on mortality in COVID-19 pneumonia patients.
Cardiovasc J Afr. 2023;34(1):16-22. doi: 10.5830/CVJA-2022-017. Epub 2022 May 16.
9
Haemostatic differences between SARS-CoV-2 PCR-positive and negative patients at the time of hospital admission.
PLoS One. 2022 Apr 28;17(4):e0267605. doi: 10.1371/journal.pone.0267605. eCollection 2022.
10
The association between the CT severity index and the pulmonary artery area in COVID-19 pneumonia.
Acta Radiol. 2023 Jul;64(7):2238-2244. doi: 10.1177/02841851211070491. Epub 2022 Jan 24.
本文引用的文献
1
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
2
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
3
Acute Respiratory Distress Syndrome as an Organ Phenotype of Vascular Microthrombotic Disease: Based on Hemostatic Theory and Endothelial Molecular Pathogenesis.
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619887437. doi: 10.1177/1076029619887437.
5
Pulmonary Thrombosis: A Clinical Pathological Entity Distinct from Pulmonary Embolism?
Semin Thromb Hemost. 2019 Nov;45(8):778-783. doi: 10.1055/s-0039-1696942. Epub 2019 Sep 19.
6
Inhibition of the extrinsic or intrinsic coagulation pathway during pneumonia-derived sepsis.
Am J Physiol Lung Cell Mol Physiol. 2018 Nov 1;315(5):L799-L809. doi: 10.1152/ajplung.00014.2018. Epub 2018 Aug 23.
7
The role of mononuclear phagocytes in Ebola virus infection.
J Leukoc Biol. 2018 Oct;104(4):717-727. doi: 10.1002/JLB.4RI0518-183R. Epub 2018 Aug 10.
8
The coagulation system in host defense.
Res Pract Thromb Haemost. 2018 May 24;2(3):549-557. doi: 10.1002/rth2.12109. eCollection 2018 Jul.
9
Pathogenesis and diagnosis of disseminated intravascular coagulation.
Int J Lab Hematol. 2018 May;40 Suppl 1:15-20. doi: 10.1111/ijlh.12830.
10
Case report: severe cytomegalovirus primary infection in an immunocompetent adult with disseminated intravascular coagulation treated with valganciclovir.
BMC Infect Dis. 2016 Jan 19;16:19. doi: 10.1186/s12879-016-1343-3.
Zotero 插件